Correlation Between Sana Biotechnology and Arcus Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Arcus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Arcus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Arcus Biosciences, you can compare the effects of market volatilities on Sana Biotechnology and Arcus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Arcus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Arcus Biosciences.

Diversification Opportunities for Sana Biotechnology and Arcus Biosciences

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sana and Arcus is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Arcus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcus Biosciences and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Arcus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcus Biosciences has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Arcus Biosciences go up and down completely randomly.

Pair Corralation between Sana Biotechnology and Arcus Biosciences

Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the Arcus Biosciences. In addition to that, Sana Biotechnology is 1.27 times more volatile than Arcus Biosciences. It trades about -0.39 of its total potential returns per unit of risk. Arcus Biosciences is currently generating about -0.04 per unit of volatility. If you would invest  1,666  in Arcus Biosciences on August 29, 2024 and sell it today you would lose (87.00) from holding Arcus Biosciences or give up 5.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sana Biotechnology  vs.  Arcus Biosciences

 Performance 
       Timeline  
Sana Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sana Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Arcus Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arcus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Sana Biotechnology and Arcus Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sana Biotechnology and Arcus Biosciences

The main advantage of trading using opposite Sana Biotechnology and Arcus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Arcus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcus Biosciences will offset losses from the drop in Arcus Biosciences' long position.
The idea behind Sana Biotechnology and Arcus Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas